Nanomedicine, Volume IIA: Biocompatibility
© 2003 Robert A. Freitas Jr. All Rights Reserved.
Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003
References 2900-2999
2900. P.A. Kramer, T. Burnstein, “Phagocytosis of microspheres containing an anticancer agent by tumor cells in vitro,” Life Sci. 19(15 August 1976):515-519.
2901. M.J. Dorie, R.F. Kallman, D.F. Rapacchietta, D. Van Antwerp, Y.R Huang, “Migration and internalization of cells and polystyrene microspheres in tumor cell spheroids,” Exp. Cell Res. 141(September 1982):201-209.
2902. S.K. Pulfer, J.M. Gallo, “Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres,” J. Drug Target. 6(1998):215-227.
2903. E.A. Ling, “Ultrastructure and origin of epiplexus cells in the telencephalic choroid plexus of postnatal rats studied by intravenous injection of carbon particles,” J. Anat. 129(October 1979):479-492.
2904. Stanley Davis, “Chapter 16. Biomedical Applications of Particle Engineering,” in Richard R.H. Coombs, Dennis W. Robinson, eds., Nanotechnology in Medicine and the Biosciences, Gordon & Breach Publishers, Netherlands, 1996, pp. 243-262.
2905. M.E. Norman, P. Williams, L. Illum, “Human serum albumin as a probe for protein adsorption (opsonization) to block co-polymer coated microspheres,” Biomaterials 13(1992):841-849.
2906. H. Ayhan, E. Piskin, “Interaction of activated leukocytes with polymeric microspheres,” Int. J. Artif. Organs 20(December 1997):704-707.
2907. T.A. Gaither, I. Vargas, S. Inada, M.M. Frank, “The complement fragment C3d facilitates phagocytosis by monocytes,” Immunology 62(November 1987):405-411; 63(March 1988):559 (erratum).
2908. S.M. Moghimi, H.M. Patel, “Differential properties of organ-specific serum opsonins for liver and spleen macrophages,” Biochim. Biophys. Acta 984(18 September 1989):379-383; “Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes,” Biochim. Biophys. Acta 984(18 September 1989):384-387; “Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsonic activity,” Biochim. Biophys. Acta 1028(19 October 1990):304-308; “Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats,” Biochim. Biophys. Acta 1285(13 November 1996):56-64.
2909. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, V. Kolb-Bachofen, “Coating particles with a block copolymer suppresses opsonization but permits the activity of dysopsonins in the serum,” Biochim. Biophys. Acta 1179(1993):157-165.
2910. S.M. Moghimi, T. Gray, “A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats,” Clin. Sci. (Colch) 93(October 1997):371-379.
2911. B.E. Lehnert, C. Tech, “Quantitative evaluation of opsonin-independent phagocytosis by alveolar macrophages in monolayer using polystyrene microspheres,” J. Immunol. Methods 78(22 April 1985):337-344.
2912. O. Atwal, K. Saldanha, “Erythrophagocytosis in alveolar capillaries of goat lung: ultrastructural properties of blood monocytes,” Acta Anat. (Basel) 124(1985):245-254.
2913. G. Winkler, N. Cheville, “Postnatal colonization of porcine lung capillaries by intravascular macrophages: an ultrastructural, morphometric analysis,” Microvasc. Res. 33(1987):223-232.
2914. A.E. Warner, J.D. Brain, “Intravascular pulmonary macrophges: a novel cell removes particles from blood,” Am. J. Physiol. 250(April 1986):R728-R732; “The cell biology and pathogenic role of pulmonary intravascular macrophages,” Am. J. Physiol. 258(February 1990):L1-L12.
2915. K. Longworth, A. Westgate, M. Grady, J. Westcott, N. Staub, “Development of pulmonary intravascular macrophage function in newborn lambs,” J. Appl. Physiol. 73(1992):2608-2615.
2916. N.C. Staub, “Pulmonary intravascular macrophages,” Annu. Rev. Physiol. 56(1994):47-67.
2917. A.E. Warner, “Pulmonary intravascular macrophages. Role in acute lung injury,” Clin. Chest Med. 17(March 1996):125-135.
2918. K.E. Longworth, “The comparative biology of pulmonary intravascular macrophages,” Front. Biosci. 2(1 June 1997):d232-d241.
2919. J.D. Brain, R.M. Molina, M.M. DeCamp, A.E. Warner, “Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species,” Am. J. Physiol. 276(January 1999):L146-L154.
2920. A. Warner, B. Barry, J. Brain, “Pulmonary intravascular macrophages in sheep,” Lab. Invest. 55(1986):276-288.
2921. G. Winkler, “Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties,” Am. J. Anat. 181(1988):217-234.
2922. G.D. Niehaus, S.R. Mehendale, “Quantifying rat pulmonary intravascular mononuclear phagocytes,” Anat. Rec. 252(December 1998):626-636.
2923. A. Warner, R. Molina, J. Brain, “Uptake of bloodborne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep,” Am. Rev. Respir. Dis. 136(1987):683-690.
2924. D.J. Dehring, B.L. Wismar, “Intravascular macrophages in pulmonary capillaries of humans,” Am. Rev. Respir. Dis. 139(April 1989):1027-1029.
2925. T. Zeltner, J. Caduff, J. Gehr, J. Pfenninger, P. Burri, “The postnatal development and growth of the human lung. I. Morphometry,” Respir. Physiol. 67(1987):247-267.
2926. I. Garty, I. Tal, A. Daynan, “99mTc colloid lung uptake in a rare case of toxoplasmosis with liver involvement,” Clin. Nucl. Med. 9(1984):310-313.
2927. R. Molina, J. Brain, A. Warner, M. DeCamp, “Blood substitutes alter the fate of bacteria in the blood and may place the lungs at increased risk (Abstract),” Am. Rev. Respir. Dis. 135(1987):A84.
2928. S. Chang, N. Ohara, “Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats,” J. Clin. Invest. 94(1994):2009-2019.
2929. A. Warner, R. Molina, C. Bellows, J. Brain, “Endotoxemia enhances pulmonary mononuclear cell uptake of circulating particles and pathogens in a species without pulmonary intravascular macrophages,” Chest 105(1994):50S-51S.
2930. M. Ohata, T. Ito, “Experimental study on the fine structure of chicken liver parenchyme with special references to extrasinusoidal macrophages and sinusoidal blood cells. Part 1. Sinusoidal cells and macrophages in the normal and India ink-perfused livers,” Arch. Histol. Jpn. 49(March 1986):83-103.
2931. E. Wisse, “Ultrastructure and Function of Kupffer Cells and Other Sinusoidal Cells in the Liver, “ in E. Wisse, D.L. Knook, eds., Kupffer Cells and Other Liver Sinusoidal Cells, Elsevier/North-Holland Biomedical Press, New York, 1977, pp. 33-60.
2932. Michael H. Ross, Edward J. Reith, Lynn J. Romrell, Histology: A Text and Atlas, Second Edition, Williams & Wilkins, Baltimore MD, 1989.
2933. Robert G. Meeks, Steadman D. Harrison, Richard J. Bull, eds., Hepatotoxicology, CRC Press, Boca Raton, 1991.
2934. L. Bouwens, M. Baekeland, E. Wisse, “Cytokinetic analysis of the expanding Kupffer-cell population in rat liver,” Cell Tissue Kinet. 19(March 1986):217-226.
2935. E.H. Bloch, R.S. McCuskey, “Biodynamics of phagocytosis: an analysis of the dynamics of phagocytosis in the liver by in vivo microscopy,” in E. Wisse, D.L. Knook, eds., Kupffer Cells and Other Liver Sinusoidal Cells, Elsevier/North-Holland Biomedical Press, NY, 1977, pp. 21-32.
2936. K. Ogawara, M. Yoshida, K. Higaki, T. Kimura, K. Shiraishi, M. Nishikawa, Y. Takakura, M. Hashida, “Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution,” J. Control. Release 59(1 May 1999):15-22.
2937. Y. Shiratori, H. Jin’nai, H. Teraoka, S. Matano, K. Matsumoto, K. Kamii, M. Tanaka, K. Okano, “Phagocytic properties of hepatic endothelial cells and splenic macrophages compensating for a decreased phagocytic function of Kupffer cells in the chronically ethanol-fed rats,” Exp. Cell Biol. 57(1989):300-309.
2938. Andre Blouin, “Morphometry of liver sinusoidal cells,” in E. Wisse, D.L. Knook, eds., Kupffer Cells and Other Liver Sinusoidal Cells, Elsevier/North-Holland Biomedical Press, New York, 1977, pp. 61 et seq.
2939. C. Dan, K. Wake, “Modes of endocytosis of latex particles in sinusoidal endothelial and Kupffer cells of normal and perfused rat liver,” Exp. Cell Res. 158(May 1985):75-85.
2940. K. Yamashita, H. Fujita, S. Kawamata, “Fine structural and cytochemical aspects of granuloma formation derived from Kupffer cells in mice injected with latex particles,” Arch. Histol. Jpn. 48(July 1985):315-326.
2941. Paul A. Linnemeyer, “The Immune System – An Overview,” November 1993, Fact Sheet from the Seattle Treatment Education Project; http://www.thebody.com/step/immune.html
2942. M.A. Nolte, E.N. Hoen, A. van Stijn, G. Kraal, R.E. Mebius, “Isolation of the intact white pulp. Quantitative and qualitative analysis of the cellular composition of the splenic compartments,” Eur. J. Immunol. 30(February 2000):626-634.
2943. W.A. Kammerer, D.G. Osmond, “Surface morphology of bone marrow lymphocytes. I. Scanning electron microscopy of small lymphocytes bone marrow and spleen,” Anat. Rec. 192(November 1978):423-433.
2944. M.L. Jelachich, E.K. Lakey, L. Casten, S.K. Pierce, “Antigen presentation is a function of all B cell subpopulations separated on the basis of size,” Eur. J. Immunol. 16(April 1986):411-416.
2945. T. Witte, K. Wordelmann, R.E. Schmidt, “Heterogeneity of natural killer (NK) cells in the human spleen,” Immun. Infekt. 17(April 1989):65-67. In German.
2946. B. Steiniger, P. Barth, B. Herbst, A. Hartnell, P.R. Crocker, “The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone,” Immunology 92(October 1997):307-316.
2947. A.R. Nusrat, S.D. Wright, A.A. Aderem, R.M. Steinman, Z.A. Cohn, “Properties of isolated red pulp macrophages from mouse spleen,” J. Exp. Med. 168(1 October 1988):1505-1510.
2948. M.A. Tomai, T.J. Fitzgerald, “Splenic macrophage function in early syphilitic infection is complex. Stimulation versus down-regulation,” J. Immunol. 146(1 May 1991):3171-3176.
2949. L.H. Arp, N.F. Cheville, “Interaction of blood-borne Escherichia coli with phagocytes of spleen and liver in turkeys,” Am. J. Vet. Res. 42(April 1981):650-657.
2950. R.P. Spencer, H.A. Pearson, “The spleen as a hematological organ,” Semin. Nucl. Med. 5(January 1975):95-102.
2951. G.D. Bennett, M.M. Kay, “Homeostatic removal of senescent murine erythrocytes by splenic macrophages,” Exp. Hematol. 9(March 1981):297-307.
2952. G.M. Baerlocher, E. Schlappritzi, P.W. Straub, W.H. Reinhart, “Erythrocyte deformability has no influence on the rate of erythrophagocytosis in vitro by autologous human monocytes/macrophages,” Br. J. Haematol. 86(March 1994):629-634.
2953. I. Klonizakis, A.M. Peters, M.L. Fitzpatrick, M.J. Kensett, S.M. Lewis, J.P. Lavender, “Spleen function and platelet kinetics,” J. Clin. Pathol. 34(April 1981):377-380.
2954. B.A. Schacter, B. Yoda, L.G. Israels, “Human spleen heme oxygenase in normal, hemolytic and other pathological states,” Ann. Clin. Res. 17(1976):28-34.
2955. R.F. King, S.B. Brown, “The mechanism of haem catabolism. A study of haem breakdown in spleen microsomal fraction and in a model system by 18O labelling and metal substitution,” Biochem. J. 174(15 July 1978):103-109.
2956. J. Aster, V. Kumar, “White cells, lymph nodes, spleen, and thymus,” in R.S. Cotran, V. Kumar, T. Collins, eds., Robbins Pathologic Basis of Disease, 6th Edition, Saunders, Philadelphia PA, 1999, pp. 644-696.
2957. R. van Furth, M.M. Diesselhoff-den Dulk, “Dual origin of mouse spleen macrophages,” J. Exp. Med. 160(1 November 1984):1273-1283.
2958. S.M. Moghimi, H. Hedeman, I.S. Muir, L. Illum, S.S. Davis, “An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen,” Biochim. Biophys. Acta 1157(11 July 1993):233-240.
2959. S.M. Moghimi, “Re-establishing the long circulatory behavior of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging,” Biochim. Biophys. Acta 1472(18 October 1999):399-403.
2960. S.R. Wellhausen, M.S. Watson, “Challenge of the mononuclear phagocytic system with colloidal carbon alters lymphocyte distribution and responsiveness,” Immunol. Invest. 19(April 1990):185-197.
2961. Jerome S. Burke, Gerard T. Simon, “Electron microscopy of the spleen. II. Phagocytosis of colloidal carbon,” Am. J. Pathol. 58(January 1970):157-181.
2962. K. Matsuno, T. Schaffner, H.A. Gerber, C. Ruchti, M.W. Hess, H. Cottier, “Uptake by enterocytes and subsequent translocation to internal organs, e.g., the thymus, of Percoll microspheres administered per os to suckling mice,” J. Reticuloendothel. Soc. 33(April 1983):263-273.
2963. U. Gaur, S.K. Sahoo, T.K. De, P.C. Ghosh, A. Maitra, P.K. Ghosh, “Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system,” Int. J. Pharm. 202(20 July 2000):1-10.
2964. K. Miyakawa, K. Matsuno, J. Ohmori, M. Kotani, “Localization in the rat spleen of carbon-laden macrophages introduced into the splenic artery: a subpopulation of macrophages entering the white pulp,” Anat. Rec. 227(August 1990):464-474.
2965. K. Matsuno, K. Miyakawa, M. Kotani, “Macrophages migrate from the marginal zone into the germinal centre of the rodent spleen,” Adv. Exp. Med. Biol. 186(1985):421-426.
2966. Y. Shikama et al, “Granuloma formation by artificial microparticles in vitro. Macrophages and monokines play a critical role in granuloma formation,” Am. J. Pathol. 134(June 1989):1189-1199.
2967. I.Y. Sato, K. Kobayashi, N. Yamagata, Y. Shikama, T. Kasama, K. Kasahara, T. Takahashi, “Modulation of granuloma formation in vitro by endogenous mediators,” Immunopharmacology 21(March-April 1991):73-82.
2968. E.E. Okon, D. Pulikan, A.E. Pereverzev, B.N. Kudriavtsev, P. Zhale, “Toxicity of magnetite-dextran particles: morphological study,” Tsitologiia 42(2000):358-366. In Russian.
2969. S. Levine, R. Sowinski, S. Koulish, “Plasmacellular and granulomatous splenomegaly produced in rats by tin,” Exp. Mol. Pathol. 39(December 1983):364-376.
2970. R.J. Marshall, A.G. MacIver, “The monocyte/macrophage population of the normal human kidney,” J. Pathol. 143(August 1984):275-280.
2971. R. de Water, C. Noordermeer, A.B. Houtsmuller, A.L. Nigg, T. Stijnen, F.H. Schroder, D.J. Kok, “Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium,” Am. J. Kidney Dis. 36(September 2000):615-625.
2972. V. Camp, P. Martin, “The role of macrophages in clearing programmed cell death in the developing kidney,” Anat. Embryol. (Berl) 194(October 1996):341-348.
2973. M. Yasui, H. Tanaka, Y. Seino, “The role of tissue-fixed macrophages in apoptosis in the developing kidney,” Nephron 77(1997):325-332.
2974. S. Arima, M. Nakayama, M. Naito, T. Sato, K. Takahashi, “Significance of mononuclear phagocytes in IgA nephropathy,” Kidney Int. 39(April 1991):684-692.
2975. I. Bodi, A.A. Abraham, P.L. Kimmel, “Macrophages in human immunodeficiency virus-associated kidney diseases,” Am. J. Kidney Dis. 24(November 1994):762-767.
2976. C. Marin, J. Mosquera, B. Rodriguez-Iturbe, “Neuraminidase promotes neutrophil, lymphocyte and macrophage infiltration in the normal rat kidney,” Kidney Int. 47(January 1995):88-95.
2977. G.F. Schreiner, “The mesangial phagocyte and its regulation of contractile cell biology,” J. Am. Soc. Nephrol. 2(April 1992):S74-S82.
2978. G.F. Schreiner, E.R. Unanue, “Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen,” Lab. Invest. 51(November 1984):515-523.
2979. R. Mancilla-Jimenez, B. Bellon, J. Kuhn, M.F. Belair, M. Rouchon, P. Druet, J. Bariety, “Phagocytosis of heat-aggregated immunoglobulins by mesangial cells: an immunoperoxidase and acid phosphatase study,” Lab. Invest. 46(March 1982):243-253.
2980. V. Cattell, A. Gaskin de Urdaneta, S. Arlidge, J.E. Collar, A. Roberts, J. Smith, “Uptake and clearance of ferritin by the glomerular mesangium. I. Phagocytosis by mesangial cells and blood monocytes,” Lab. Invest. 47(September 1982):296-303.
2981. L. Baud, J. Hagege, J. Sraer, E. Rondeau, J. Perez, R. Ardaillou, “Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity,” J. Exp. Med. 158(1 December 1983):1836-1852.
2982. J. Hughes, Y. Liu, J. Van Damme, J. Savill, “Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD-36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion,” J. Immunol. 158(1 May 1997):4389-4397.
2983. J.D. Elema, J.R. Hoyer, R.L. Vernier, “The glomerular mesangium: uptake and transport of intravenously injected colloidal carbon in rats,” Kidney Int. 9(May 1976):395-406.
2984. S.M. Mauer, M. Numata, D.E. Sutherland, “The effects of polyvinyl alcohol on the uptake and processing of colloidal carbon by the glomerular mesangium in rats,” Lab. Invest. 41(December 1979):475-482.
2985. J. Grond, J.D. Elema, “Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat,” Lab. Invest. 45(November 1981):400-409.
2986. T. Ishiyama, “Functional and morphological studies of the glomerular mesangium. II. Uptake and transport of carbon particles in the mesangium of normal rabbit kidney,” Nippon Jinzo Gakka Shi 25(April 1983):397-414.
2987. T. Nagamatsu, Y. Suzuki, “Effects of prostaglandin E1 and dipyridamole on disposal of colloidal carbon via glomerular mesangial channels,” Jpn. J. Pharmacol. 45(September 1987):1-6.
2988. K. Kume, “Influence of Coxsackie B4 virus on uptake and transport of colloidal carbon by glomerular mesangium,” Nippon Jinzo Gakkai Shi 32(July 1990):777-789. In Japanese.
2989. M. Kimura, M. Nagase, A. Hishida, N. Honda, “Intramesangial passage of mononuclear phagocytes in murine lupus glomerulonephritis,” Am. J. Pathol. 127(April 1987):149-156.
2990. M. Sano, “Participation of monocytes in glomerulonephritis in acute serum sickness of rabbit,” Acta Pathol. Jpn. 26(July 1976):423-433.
2991. R.P. Cornell, “Reticuloendothelial hyperphagocytosis occurs in streptozotocin-diabetic rats. Studies with colloidal carbon, albumin microaggregates, and soluble fibrin monomers,” Diabetes 31(February 1982):110-118.
2992. H. Ditrich, H. Splechtna, “Processing of colloidal gold particles in the glomerular mesangium and macula densa of the duck kidney,” Tissue Cell 20(1988):891-898.
2993. M.F. McEntee, M.D. Ficken, “Blood clearance of radiolabeled gold colloid by the turkey mononuclear phagocytic system,” Avian Dis. 34(April-June 1990):393-397.
2994. O. Hauger, C. Delalande, H. Trillaud, C. Deminiere, B. Quesson, H. Kahn, J. Cambar, C. Combe, N. Grenier, “MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome,” Magn. Reson. Med. 41(January 1999):156-162; Y. Zhang, S.J. Dodd, K.S. Hendrich, M. Williams, C. Ho, “Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration,” Kidney Int. 58(September 2000):1300-1310.
2995. L. Baud, J. Perez, R. Ardaillou, “Dexamethasone and hydrogen peroxide production by mesangial cells during phagocytosis,” Am. J. Physiol. 250(April 1986):F596-F604.
2996. S. Toyabe, T. Iwanaga, “An ultrastructural study of proliferative nephritis induced experimentally by a monoclonal antibody against mesangial cells: replacement of mesangial cells by cells of the monocyte-macrophage system,” Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol. 61(1992):397-407.
2997. H.Y. Lan, D.J. Nikolic-Paterson, R.C. Atkins, “Trafficking of inflammatory macrophages from the kidney to draining lymph nodes during experimental glomerulonephritis,” Clin. Exp. Immunol. 92(May 1993):336-341.
2998. R.H. Beelen, W.S. Walker, “Dynamics of cytochemically distinct subpopulations of macrophages in elicited rat peritoneal exudates,” Cell Immunol. 82(December 1983):246-257; P.S. Morahan, M.A. Rozner, E.J. Jessee, “Effect of elicitation on peritoneal macrophage subpopulations: size distributions, ectoenzyme phenotypes and antitumor activity,” Int. J. Cancer 30(15 December 1982):787-794.
2999. B.E. Lehnert, “Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung,” Environ. Health Perspect. 97(July 1992):17-46.
Last updated on 16 April 2004